|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/94 | |
| G01N 33/50 |
| (11) | Patento numeris | 2052256 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07788437.7 |
| Europos patento paraiškos padavimo data | 2007-08-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-04-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-02-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2007/058458 |
| Data | 2007-08-15 |
| (87) | Numeris | WO 2008/020043 |
| Data | 2008-02-21 |
| (30) | Numeris | Data | Šalis |
| 465191 | 2006-08-17 | US |
| (72) |
AMANN ZALAN, Ildiko, DE
MOECKS, Joachim, DE
BURGER, Hans Ulrich, DE
ESCRIG, Cesar, CH
SCHERHAG, Armin, CH
DOUGHERTY, Frank, FR
HERRMANN, Zuzana, DE
|
| (73) |
Roche Diagnostics GmbH,
Sandhofer Strasse 116, 68305 Mannheim,
DE
F. Hoffmann-La Roche AG, Grenzacherstrasse 124, 4070 Basel, CH |
| (54) | THE USE OF BNP-TYPE PEPTIDES FOR THE STRATIFICATION OF THERAPY WITH ERYTHROPOIETIC STIMULATING AGENTS |
| THE USE OF BNP-TYPE PEPTIDES FOR THE STRATIFICATION OF THERAPY WITH ERYTHROPOIETIC STIMULATING AGENTS |